TABLE 5.
β-Lactamase inhibitor | β-Lactam | Model | Period (days) | Derived PK/PD index | Reference |
---|---|---|---|---|---|
Avibactam | Ceftazidime | Hollow fiber; entericsa | 1 | CT ≥0.5 mg/liter maintained β-lactamase-null phenotype | 43 |
Avibactam | Ceftazidime | Neutropenic mouse thigh; P. aeruginosa | 1 | fT>CT 1 mg/liter | 44 |
Avibactam | Ceftazidime | Neutropenic mouse lung; P. aeruginosa | 1 | fT>CT 1 mg/liter | 44 |
Avibactam | Aztreonam | Hollow fiber; enterics | 1 | fT>CT 2–2.5 mg/liter | 49 |
Avibactam | Aztreonam | Neutropenic mouse thigh; enterics | 1 | fT>CT 2–2.5 mg/liter | 49 |
Avibactam | Ceftaroline | Hollow fiber; enterics | 10–13 | fT>CT | 50 |
Avibactam | Ceftazidime | Constant-volume fermenter; enterics | 1 | fAUC | 51 |
Avibactam | Ceftaroline | Constant-volume fermenter; enterics | 1 | fAUC | 51 |
Enterics, Enterobacteriaceae.